Journal of Pediatric Neurology 2016; 14(03): 105-109
DOI: 10.1055/s-0036-1587600
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Childhood-onset Systemic Lupus Erythematosus Complicated by Posterior Reversible Encephalopathy Syndrome in The Context of Kidney Dialysis and Plasma Exchange in Pediatric Lupus

Natasha M. Ruth
1   Division of Pediatric Rheumatology, Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, United States
,
Timothy Amrhein
2   Division of Neuroradiology, Department of Radiology, Medical University of South Carolina, Charleston, South Carolina, United States
,
Murray Passo
1   Division of Pediatric Rheumatology, Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, United States
,
Gary Gilkeson
3   Division of Rheumatology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States
› Author Affiliations
Further Information

Publication History

08 August 2014

20 April 2016

Publication Date:
11 August 2016 (online)

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a neurotoxic condition characterized by reversible vasogenic edema on neuroimaging. Its various manifestations include altered mental status, headache, visual changes, and seizure activity along with a primarily posterior leukoencephalopathy on imaging studies. PRES has been found in the setting of eclampsia, hypertension, uremia, malignancy, transplantation, autoimmune disease, and/or the use of immunosuppressive drugs (specifically cyclosporine). Recently, it has been described more frequently in children with systemic lupus erythematosus (SLE) and it is often difficult to distinguish from central nervous system lupus. In this paper, we describe five cases of pediatric SLE complicated by PRES. Three of the patients were receiving dialysis, one was receiving plasmapheresis. None of the patients were on cyclosporine. In our center, we follow over 60 children with SLE and these are the only five cases diagnosed with PRES as part of their disease course. Many of our patients have associated lupus nephritis and hypertension and are on multiple immunosuppressive medications. We hypothesize that it is the fluid shifts and rapid increase in blood pressure during these treatments that contributed to the development of PRES in these patients.

 
  • References

  • 1 Chen HA, Lin YJ, Chen PC, Chen TY, Lin KC, Cheng HH. Systemic lupus erythematosus complicated with posterior reversible encephalopathy syndrome and intracranial vasculopathy. Int J Rheum Dis 2010; 13 (4) e79-e82
  • 2 Hinchey J, Chaves C, Appignani B , et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334 (8) 494-500
  • 3 Muscal E, Traipe E, de Guzman MM, Myones BL, Brey RL, Hunter JV. MR imaging findings suggestive of posterior reversible encephalopathy syndrome in adolescents with systemic lupus erythematosus. Pediatr Radiol 2010; 40 (7) 1241-1245
  • 4 Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008; 29 (6) 1036-1042
  • 5 Girişgen I, Tosun A, Sönmez F, Ozsunar Y. Recurrent and atypical posterior reversible encephalopathy syndrome in a child with peritoneal dialysis. Turk J Pediatr 2010; 52 (4) 416-419
  • 6 Onder AM, Lopez R, Teomete U , et al. Posterior reversible encephalopathy syndrome in the pediatric renal population. Pediatr Nephrol 2007; 22 (11) 1921-1929
  • 7 Ergün T, Lakadamyali H, Yilmaz A. Recurrent posterior reversible encephalopathy syndrome in a hypertensive patient with end-stage renal disease. Diagn Interv Radiol 2008; 14 (4) 182-185
  • 8 Bartynski WS, Boardman JF. Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2008; 29 (3) 447-455
  • 9 Arboix A, Bechich S, Oliveres M, García-Eroles L, Massons J, Targa C. Ischemic stroke of unusual cause: clinical features, etiology and outcome. Eur J Neurol 2001; 8 (2) 133-139
  • 10 Aksoy DY, Arici M, Kiykim AA , et al. Posterior leukoencephalopathy and nephrotic syndrome: just a coincidence?. Am J Med Sci 2004; 327 (3) 156-159
  • 11 Pearson ER, D'Souza RJ, Hamilton-Wood C, Nicholls AJ, Beaman M. Hypertensive encephalopathy and nephrotic syndrome: a possible link?. Nephrol Dial Transplant 1999; 14 (7) 1750-1752
  • 12 Ikeda M, Ito S, Hataya H, Honda M, Anbo K. Reversible posterior leukoencephalopathy in a patient with minimal-change nephrotic syndrome. Am J Kidney Dis 2001; 37 (4) E30
  • 13 Ikeda M, Yata N, Kamei K , et al. Posterior leukoencephalopathy syndrome in pediatric patients with kidney disease. Pediatr Nephrol 2002; 17 (1) 71
  • 14 Nakahara C, Hasegawa N, Izumi I, Kanemoto K, Iwasaki N. The use of cyclosporine in a boy with a prior episode of posterior encephalopathy. Pediatr Nephrol 2005; 20 (5) 657-661
  • 15 Lewis DM, Tooke JE, Beaman M, Gamble J, Shore AC. Peripheral microvascular parameters in the nephrotic syndrome. Kidney Int 1998; 54 (4) 1261-1266
  • 16 Ishikura K, Hamasaki Y, Sakai T , et al. Children with posterior reversible encephalopathy syndrome associated with atypical diffusion-weighted imaging and apparent diffusion coefficient. Clin Exp Nephrol 2011; 15 (2) 275-280
  • 17 Pasupuleti DV, Miranda M, Vattipally V. Case report: posterior reversible encephalopathy syndrome. Am Fam Physician 2005; 72 (12) 2430 , 2434, 2496